300 related articles for article (PubMed ID: 9412703)
21. Human immunodeficiency virus-associated rheumatic disorders in the HAART era.
Marquez J; Restrepo CS; Candia L; Berman A; Espinoza LR
J Rheumatol; 2004 Apr; 31(4):741-6. PubMed ID: 15088301
[TBL] [Abstract][Full Text] [Related]
22. Anti-CD95 (APO-1/Fas) autoantibodies and T cell depletion in human immunodeficiency virus type 1 (HIV-1)-infected children.
Stricker K; Knipping E; Böhler T; Benner A; Krammer PH; Debatin KM
Cell Death Differ; 1998 Mar; 5(3):222-30. PubMed ID: 10200468
[TBL] [Abstract][Full Text] [Related]
23. Distinctive rheumatic manifestations in 98 patients with human immunodeficiency virus infection in China.
Zhang X; Li H; Li T; Zhang F; Han Y
J Rheumatol; 2007 Aug; 34(8):1760-4. PubMed ID: 17659750
[TBL] [Abstract][Full Text] [Related]
24. Rheumatic manifestations in human immunodeficiency virus positive and negative individuals: a study of 2 populations with similar risk factors.
Medina-Rodriguez F; Guzman C; Jara LJ; Hermida C; Alboukrek D; Cervera H; Miranda JM; Fraga A
J Rheumatol; 1993 Nov; 20(11):1880-4. PubMed ID: 8308773
[TBL] [Abstract][Full Text] [Related]
25. Surface immunoglobulin-positive T lymphocytes in HIV-1 infection: relationship to CD4+ lymphocyte depletion.
Ardman B; Mayer K; Bristol J; Ryan M; Settles M; Levy E
Clin Immunol Immunopathol; 1990 Aug; 56(2):249-58. PubMed ID: 1974180
[TBL] [Abstract][Full Text] [Related]
26. Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection.
Whittle H; Egboga A; Todd J; Corrah T; Wilkins A; Demba E; Morgan G; Rolfe M; Berry N; Tedder R
AIDS; 1992 Jul; 6(7):685-9. PubMed ID: 1354448
[TBL] [Abstract][Full Text] [Related]
27. B lymphocyte stimulator protein-associated increase in circulating autoantibody levels may require CD4+ T cells: lessons from HIV-infected patients.
Stohl W; Cheema GS; Briggs WS; Xu D; Sosnovtseva S; Roschke V; Ferrara DE; Labat K; Sattler FR; Pierangeli SS; Hilbert DM
Clin Immunol; 2002 Aug; 104(2):115-22. PubMed ID: 12165272
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of enzyme-linked immunosorbent and alternative assays for detection of HIV antibodies using panels of Brazilian sera.
Ivo-Dos-Santos J; Mello DL; Couto-Fernandez JC; Passos RM; Dias-Carneiro LA; Castilho EA; Galvão-Castro B
Rev Inst Med Trop Sao Paulo; 1990; 32(2):96-100. PubMed ID: 2095632
[TBL] [Abstract][Full Text] [Related]
29. Neutralizing and enhancing antibodies measured in complement-restored serum samples from HIV-1-infected individuals correlate with immunosuppression and disease.
Füst G; Tóth FD; Kiss J; Ujhelyi E; Nagy I; Bánhegyi D
AIDS; 1994 May; 8(5):603-9. PubMed ID: 7914732
[TBL] [Abstract][Full Text] [Related]
30. Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire.
Mukadi Y; Perriëns JH; St Louis ME; Brown C; Prignot J; Willame JC; Pouthier F; Kaboto M; Ryder RW; Portaels F
Lancet; 1993 Jul; 342(8864):143-6. PubMed ID: 8101257
[TBL] [Abstract][Full Text] [Related]
31. HIV-1 IgA specific serum antibodies and disease progression during HIV-1 infection.
Margalith M; Levy E; Rinaldo CR; Detels R; Phair J; Kaslow R; Saah AJ; Sarov B
J Hum Virol; 2001; 4(5):269-77. PubMed ID: 11907384
[TBL] [Abstract][Full Text] [Related]
32. Serum non-organ specific autoantibodies in human immunodeficiency virus 1 infection.
Cassani F; Baffoni L; Raise E; Selleri L; Monti M; Bonazzi L; Gritti FM; Bianchi FB
J Clin Pathol; 1991 Jan; 44(1):64-8. PubMed ID: 1671787
[TBL] [Abstract][Full Text] [Related]
33. Determination of T-lymphocyte subsets on site in rural Tanzania: results in HIV-1 infected and non-infected individuals.
Levin A; Brubaker G; Shao JS; Kumby D; O'Brien TR; Goedert JJ; Strauss KW; Blattner WA; Hannet I
Int J STD AIDS; 1996 Jul; 7(4):288-91. PubMed ID: 8876362
[TBL] [Abstract][Full Text] [Related]
34. Increase in plasma IL-10 levels and rapid loss of CD4+ T cells among HIV-infected individuals in south India.
Srikanth P; Castillo RC; Sridharan G; John TJ; Zachariah A; Mathai D; Schwartz DH
Int J STD AIDS; 2000 Jan; 11(1):49-51. PubMed ID: 10667901
[TBL] [Abstract][Full Text] [Related]
35. Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.
French M; Keane N; McKinnon E; Phung S; Price P
HIV Med; 2007 Apr; 8(3):148-55. PubMed ID: 17461858
[TBL] [Abstract][Full Text] [Related]
36. Dermatoses among Brazilian HIV-positive patients: correlation with the evolutionary phases of AIDS.
Rosatelli JB; Machado AA; Roselino AM
Int J Dermatol; 1997 Oct; 36(10):729-34. PubMed ID: 9372345
[TBL] [Abstract][Full Text] [Related]
37. Antiphospholipid antibodies in HIV-positive patients.
Galrão L; Brites C; Atta ML; Atta A; Lima I; Gonzalez F; Magalhães F; Santiago M
Clin Rheumatol; 2007 Nov; 26(11):1825-30. PubMed ID: 17332976
[TBL] [Abstract][Full Text] [Related]
38. HIV infection and rheumatic diseases--autoimmune mechanisms in immunodeficient hosts.
Weyand CM; Goronzy JJ
Z Rheumatol; 1992; 51(2):55-64. PubMed ID: 1535472
[TBL] [Abstract][Full Text] [Related]
39. The frequency of blood-born viral infections in a population of multitransfused Brazilian patients.
Covas DT; Boturão Neto E; Zago MA
Rev Inst Med Trop Sao Paulo; 1993; 35(3):271-3. PubMed ID: 8278757
[TBL] [Abstract][Full Text] [Related]
40. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients].
Vial PA; Ferreccio C; Abarca K; Ortiz E; Noriega M; Pérez C; Labarca J; Torres M; Ferrés M; González C; Acuña G
Rev Med Chil; 1996 May; 124(5):525-35. PubMed ID: 9035503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
